Recapitulating primary immunodeficiencies with expanded potential stem cells: Proof of concept with STAT1 gain of function

Inborn errors of immunity (IEI) often lack specific disease models and personalized management. Signal transducer and activator of transcription (STAT)-1 gain of function (GoF) is such an example of an IEI with diverse clinical phenotype with unclear pathomechanisms and unpredictable response to therapy.1-3 First described in 2011 as an autosomal-dominant chronic mucocutaneous candidiasis (CMC) disease, the spectrum of STAT1-GoF manifestations and severity varies greatly, even among family members harboring the same germline mutation.
Source: Journal of Allergy and Clinical Immunology - Category: Allergy & Immunology Authors: Source Type: research